ISC26 Podcasts – Late-Breaking Science & Debates
Sessions: February 4–6, 2026
Ernest N. Morial Convention Center | New Orleans, Louisiana
Listen to condensed recaps of some of the most exciting sessions and presentations
Now available in podcast form: Get the highlights of some of the most talked-about sessions and features from International Stroke Conference 2026.
These podcasts use AI to condense talking points and spotlight pertinent discoveries.
Disclaimer:
By participating at the International Stroke Conference and associated events, be advised that some activities available for participants will use Artificial Intelligence (AI) as part of the experience. This includes, but is not limited to, monitoring event participation with some exhibits, the use of AI to summarize event sessions and social media posts, the creation of podcasts, AI enabled photo booths, and anonymized facial scanning analytics to gather participant sentiment. Because AI generated content may occasionally contain inaccuracies or mispronunciations, participants should be aware of these potential limitations.
If you have any questions about the AI that is being used, please reach out to [email protected].
Opening Main Event
CHOICE 2
LBS2: The Chemical Optimization of Cerebral Embolectomy (CHOICE2) Trial: Main Results
Angel Chamorro | Hospital Clinic Barcelona, Barcelona, Spain
See CHOICE2 study details and watch an interview with Dr. Chamorro in ISC26 Science News
See this and other Opening Session abstracts on the Online Program Planner(link opens in new window)
FASTEST
Recombinant Factor VIIa for Spontaneous Intracerebral Hemorrhage within Two Hours of Onset
Joseph P Broderick | University of Cincinnati, Cincinnati, OH
See FASTEST study details and watch an interview with Dr. Broderick in ISC26 Science News
See this and other Opening Session abstracts on the Online Program Planner(link opens in new window)
CREST-2
The Effect of Treatment on Cognitive Function in Patients with Asymptomatic Carotid Artery Stenosis
Ronald M Lazar | University of Alabama at Birmingham, Birmingham, AL
See this and other Opening Session abstracts on the Online Program Planner(link opens in new window)
Thursday Main Event
OCEANIC-STROKE
Factor XIa Inhibition with Asundexian in Acute Non-Cardioembolic Stroke or High-Risk Transient Ischemic Attack: Primary Results of the OCEANIC-STROKE Trial
Mukul Sharma, MD, MSc | Population Health Research Institute (ONT)
See OCEANIC STROKE summary slide, news release, interview with Dr. Sharma on ISC26 Science News
OPTION
Tenecteplase for acute non-large vessel occlusion at 4.5-24 hours
Junwei Hao, Xuanwu Hospital, Beijing, China
ATTENTION LATE
Intravenous Tenecteplase Plus Endovascular Thrombectomy Versus Endovascular Thrombectomy Alone on 4.5 to 24 Hours After Stroke Due to Basilar Artery Occlusion - a Multicenter, Randomized Controlled, Clinical Trial
Rui Li, The First Affiliated Hospital of USTC, Hefei, China
STRATEGY
Tirofiban for Branch Atheromatous Disease-Related Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial
Yilong Wang, Beijing Tiantan Hospital, Beijing, China
DEBATE 1:
Perfusion Imaging in Acute Stroke for EVT Eligibility: Past Glory or Promise for the Future?
Presenters Involved:
Debate 1: Frédéric Clarençon, Marios Psychogios
Debate 2: Thanh Nguyen, Bruce Campbell
DEBATE 2:
A Child Shows Up In An Adult Emergency Room: To Reperfuse or Not to Reperfuse? That Is the Question
Lori Jordan, Lisa Sun, Mesha Martinez, Bryan Pukenas
DEBATE 3:
Silent Strokes, Loud Consequences: The true impact of covert brain infarct
Eric Smith, Joanna Wardlaw, Guido Falcone, Rebecca Gottesman, David Thaler, Luciano Sposato
Closing Main Event
SPAN2
Final Results of the SPAN2 Trial
Patrick D Lyden, USC, Los Angeles, CA
I-ACQUIRE
The I-ACQUIRE Trial of Constraint Induced Movement Therapy for Infants/Toddlers with Perinatal Arterial Ischemic Stroke
Sharon Landesman Ramey, Fralin Biomedical Research Inst., Roanoke, VA
LAIS
Loberamisal for Acute Ischaemic Stroke (LAIS): A multicenter, randomized, double-blind, parallel, placebo-controlled phase 3 clinical trial
Shuya Li, Beijing Tiantan Hospital, Beijing, China
LT3001
LT3001 Improves Functional Outcomes in Disabling Acute Ischemic Stroke: Results from Two Phase 2 Trials
Thomas Devlin, CHI Memorial Neuroscience Institute / Morehouse School of Medicine, Chattanooga, TN
Home Computer Interface
A randomized trial of an at-home brain computer interface therapy compared to standard exercise therapy for chronic upper extremity motor deficit after stroke
Eric Leuthardt | Washington University at St. Louis, St. Louis, MO